Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
FDA Panel Reviews ACS Indication for Rivaroxaban - Family Practice News Digital Network
FDA Panel Reviews ACS Indication for RivaroxabanFamily Practice News Digital NetworkAt the meeting, the FDA's Cardiovascular and Renal Drugs Advisory Committee considered the proposed indication for rivaroxaban, at a dose of 2
FDA will favor rivaroxaban for ACS indications at May 23 panel - TheHeart.Org
FDA will favor rivaroxaban for ACS indications at May 23 panelTheHeart
Glenmark gets tentative US nod for migraine treatment drug - Moneycontrol.com
Moneycontrol
Glenmark Generics gets US FDA tentative nod for zolmitriptan tablets - pharmabiz.com
Glenmark Generics gets US FDA tentative nod for zolmitriptan tabletspharmabiz
Orchid Pharma gets FDA nod for Naratriptan tablets - Moneylife Personal Finance site and magazine
Orchid Pharma gets FDA nod for Naratriptan tabletsMoneylife Personal Finance site and magazineMumbai: Chennai-based pharma company, Orchid Chemicals & Pharmaceuticals Ltd on Wendesday announced that it has received approval from US FDA for its ANDA (Abbreviated New Drug Application) for Naratriptan tablets in the 1 mg and 2